Back to search

Article

Bleomycin alters intratumoral immune response of EBV-associated gastric cancer by ENTPD8 and PCOLCE2

2023-05-24

Abstract excerpt

<title>Abstract</title><p>Background EBV-associated gastric cancer (EBVaGC) with high PD-L1 level, is most likely to be the next subgroup benefited from immunotherapy. However, complicated with histological and aetiological heterogeneity, tolerance persists which was usually alleviated by clinical adjuvant chemotherapy (bleomycin). Identifying biomarkers of intratumoral immune response was critical for further und...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db13ad93-f26e-51d6-b562-65063d851c3f
DOI
10.21203/rs.3.rs-2958586/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bleomycin alters intratumoral immune response of EBV-associated gastric cancer by ENTPD8 and PCOLCE2DOI 10.21203/rs.3.rs-2958586/v1
Select a neighboring publication to make it the new centre.